TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Merck Life Science AB
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 1,322,751 | 929,235 | 746,094 |
Financial expenses | 1,225 | 30 | 69 |
Earnings before taxes | 711,031 | 617,209 | 473,856 |
EBITDA | 707,339 | 617,130 | 473,890 |
Total assets | 917,612 | 577,076 | 606,140 |
Current assets | 902,830 | 501,419 | 536,204 |
Current liabilities | 133,124 | 67,453 | 67,363 |
Equity capital | 773,679 | 503,607 | 537,088 |
- share capital | 10,300 | 10,300 | 10,300 |
Employees (average) | 46 | 29 | 29 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 84.3% | 87.3% | 88.6% |
Turnover per employee | 28,755 | 32,043 | 25,727 |
Profit as a percentage of turnover | 53.8% | 66.4% | 63.5% |
Return on assets (ROA) | 77.6% | 107.0% | 78.2% |
Current ratio | 678.2% | 743.4% | 796.0% |
Return on equity (ROE) | 91.9% | 122.6% | 88.2% |
Change turnover | 393,516 | 183,141 | 55,710 |
Change turnover % | 42% | 25% | 8% |
Chg. No. of employees | 17 | 0 | 1 |
Chg. No. of employees % | 59% | 0% | 4% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.